I have a strong interest in the HCV space and posted information for new people seeking knowledge. There would be quite a few at this point in time. I am allowed to have an opinion about value and reporting standards. Personal jibes and playing you said, he said, are meek. Did any one else bother to report those two new and very relevant trial results?
Where you smart enough to sell your holdings when the price was so overinflated?
Maybe it was you who missed out.
bits and pieces , page-7
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
